Stock Update
With Fed rate cut, small-cap stocks might finally be winners again
It has been a long time since investors showed any love for small-cap stocks, which have been shunned while the S&P 500 and Nasdaq have soared on tech-driven bull runs.
Read more about With Fed rate cut, small-cap stocks might finally be winners again
“The mother of all bear traps?” Hims & Hers stock snaps back after FDA warning
Shares rebounded nearly 10% after a sharp sell-off, with analysts split on whether the FDA scrutiny is noise or a sign that growth is cooling.
Read more about “The mother of all bear traps?” Hims & Hers stock snaps back after FDA warning
From streets to skies: Uber bets on drones as the next frontier of Eats
Uber is looking to bolster its service by announcing on Thursday that it has made its first investment in drone delivery through a strategic partnership with Flytrex, Inc.
Read more about From streets to skies: Uber bets on drones as the next frontier of Eats
IonQ will work with the U.S. Department of Energy to deploy quantum tech in space
IonQ (IONQ) said on Wednesday that it has signed a memorandum of understanding (MOU) with the U.S. Department of Energy (DOE) to accelerate the advancement and deployment of quantum technologies in space.
Read more about IonQ will work with the U.S. Department of Energy to deploy quantum tech in space
Nvidia partners with CoreWeave and Microsoft to launch ‘AI industrial revolution’ in the UK
It turns out Google isn’t the only American Big Tech company hopping across the pond to support the UK’s AI expansion efforts.
Read more about Nvidia partners with CoreWeave and Microsoft to launch ‘AI industrial revolution’ in the UK
Micron’s (MU) record run faces Musk-inspired doubts
Investors see HBM as Micron’s golden ticket in the AI boom. Elon Musk isn’t so sure.
Read more about Micron’s (MU) record run faces Musk-inspired doubts
FDA accuses Hims & Hers of violations for ‘false or misleading’claims about weight-loss drugs
The U.S. Food and Drug Administration (FDA) has sent a letter to Hims & Hers Health (HIMS) CEO Andrew Dudum
Read more about FDA accuses Hims & Hers of violations for ‘false or misleading’claims about weight-loss drugs
From Brussels’ doghouse to Britain’s backyard: Google bets billions on UK AI
A couple of weeks after having been hit with €2.95 billion (USD $3.5 billion) fine by the European Commission for breaching EU antitrust rules, Alphabet’s Google (GOOG) announced that it is opening a new AI data center in the UK
Read more about From Brussels’ doghouse to Britain’s backyard: Google bets billions on UK AI
Rivian’s social media buzz meets Tesla’s market reality
The EV newcomer is winning fans online and boosting brand recognition with affordable models, but with under 3% U.S. market share and mounting losses, it still has a long road ahead against Tesla’s dominance.
Read more about Rivian’s social media buzz meets Tesla’s market reality
Robinhood just opened floodgates for private markets and Wall Street is watching
Robinhood is doubling down on giving retail investors access to the private markets, announcing on Monday that it is registering with the SEC to launch a closed-end fund called Robinhood Venture Fund I (RVI).
Read more about Robinhood just opened floodgates for private markets and Wall Street is watching
WeRide and Pony AI are aggressively pushing robotaxis outside China
Both Pony AI and WeRide are making an aggressive push to expand their robotaxi services outside of Asia and into Europe and the Middle East.
Read more about WeRide and Pony AI are aggressively pushing robotaxis outside China
AI venture fund? Coreweave has quietly ripped a page from Google's playbook
Despite having only become a publicly traded company back in March, Coreweave (CRWV) said that it is already launching its own venture unit
Read more about AI venture fund? Coreweave has quietly ripped a page from Google's playbook
From red ink to billions: Uber’s stunning turnaround visualized in one chart
After years of burning cash, the ride-hailing giant is generating billions in free cash flow, delighting Wall Street, but fueling new tensions with drivers and riders
Read more about From red ink to billions: Uber’s stunning turnaround visualized in one chart
Catching a falling knife? CrowdStrike vs. Rubrik in the cybersecurity trade
Retail traders are chasing “the young CRWD” in Rubrik, but slowing growth and a smaller addressable market suggest the backup-and-recovery specialist won’t outshine CrowdStrike’s threat-detection empire anytime soon.
Read more about Catching a falling knife? CrowdStrike vs. Rubrik in the cybersecurity trade
Archer Aviation and Joby to join Trump's eVTOL pilot program
Trump’s June order to “unleash American drone dominance” also kicked off a less-covered federal eVTOL pilot program.
Read more about Archer Aviation and Joby to join Trump's eVTOL pilot program
Wall Street might finally be warming up to Adobe’s AI strategy
Although Adobe (ADBE) executives have made it clear that they are all-in on artificial intelligence, Wall Street has been slow to warm up to its execution.
Read more about Wall Street might finally be warming up to Adobe’s AI strategy
Elon Musk may have just validated his competitor, AST SpaceMobile
AST SpaceMobile (ASTS) stock slid on Elon Musk's Starlink news, but analysts say the move validates ASTS’s direct-to-cell strategy and long-term market potential.
Read more about Elon Musk may have just validated his competitor, AST SpaceMobile
Gold miners exhibit “classic stagflationary behavior,” analyst warns, as Fed scrambles for damage control
Gold stocks are soaring, equities are lagging, and the Fed is caught in a bind — a mix not seen since the 1970s.
Read more about Gold miners exhibit “classic stagflationary behavior,” analyst warns, as Fed scrambles for damage control
